cucurbitacins has been researched along with Liver Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carraz, M; Koffi-Attioua, B; Ouédraogo, N; Soro, Y; Toussaint-Douhoré, GY; Vaca-Garcia, C | 1 |
| Abd El Hameid, MK; Abou-Salim, MA; Elshaier, YAMM; Halaweish, F; Shaaban, MA | 1 |
| Abdel-Lateff, A; Alarif, WM; Ayyad, SE; Badria, FA; Ezmirly, ST; Patacchioli, FR | 1 |
| Hong, M; Ren, FB | 1 |
1 review(s) available for cucurbitacins and Liver Neoplasms
| Article | Year |
|---|---|
[Cucurbitacins in the treatment of hepatitis and primary liver cancer. Current status of pharmacological and clinical research].
Topics: Animals; Antineoplastic Agents, Phytogenic; Cucurbitacins; Hepatitis; Hepatitis, Animal; Humans; Liver Neoplasms; Triterpenes | 1986 |
3 other study(ies) available for cucurbitacins and Liver Neoplasms
| Article | Year |
|---|---|
Liver cancer antiproliferative activity of a new nor-cucurbitacin from Mareya micrantha Müll. Arg.
Topics: Cucurbitacins; Euphorbiaceae; Humans; Liver Neoplasms; Molecular Structure; Plants, Medicinal; Triterpenes | 2023 |
Design, synthesis and biological study of hybrid drug candidates of nitric oxide releasing cucurbitacin-inspired estrone analogs for treatment of hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cucurbitacins; Drug Design; Drug Screening Assays, Antitumor; Estrone; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; MAP Kinase Signaling System; Molecular Docking Simulation; Molecular Structure; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nitric Oxide; Nitric Oxide Donors; Structure-Activity Relationship | 2019 |
In vitro and in vivo study of cucurbitacins-type triterpene glucoside from Citrullus colocynthis growing in Saudi Arabia against hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Proliferation; Chromatography, Thin Layer; Citrullus; Cucurbitacins; Dose-Response Relationship, Drug; Fruit; Hep G2 Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Plants, Medicinal; Saudi Arabia; Spectrometry, Mass, Electrospray Ionization; Time Factors; Triterpenes | 2012 |